Avotaciclib

DB16652InvestigationalSmall molecule

Avotaciclib is under investigation in clinical trial NCT03579836 (Evaluation of Safety and Efficacy in BEY1107 in Monotherapy Gemcitabine Combination in Patient With Pancreatic Cancer).

Formula / weight: C₁₃H₁₁N₇O · 281.279 g/mol (avg)
Also known as: 2,6-bis(2-aminopyrimidin-4-yl)pyridin-3-ol
Code names: BEY-1107

Resolves to

Compound

UNIIZ6BYC0F36ECAS1983983-41-0

Structure

InChIKeyVFVAQKKPFOPZEA-UHFFFAOYSA-NSMILESNC1=NC=CC(=N1)C1=NC(=C(O)C=C1)C1=NC(N)=NC=C1

Targets

P06493CDK1

What you can answer from here — as of August 30, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

3Clinical trialsPhase, status and sponsor resolved per trial

Which drugs share a target with Avotaciclib, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account